Journal of Medicinal Chemistry p. 4384 - 4392 (1992)
Update date:2022-08-02
Topics:
Harris, Neil V.
Smith, Christopher
Asthon, Michael J.
Bridge, Andrew W.
Bush, Raymond C.
et al.
A potent, bioavailable ACAT inhibitor may have beneficial effects in the treatment of atherosclerosis by (i) reducing the absorption of dietary cholesterol, (ii) reducing the secretion of very low density lipoproteins into plasma from the liver, and (iii) preventing the transformation of arterial macrophages into foam cells.We have found that a mevalonate derivative 2, which contains a 4,5-diphenyl-1H-imidazol-2-yl moiety, inhibits rat hepatic microsomal ACAT in vitro and produces a significant hypocholesterolemic effect in the cholesterol-fed rat.Structure-activity relationships for analogues of 2 demonstrate that the 4,5-diphenyl-1H-imidazole moiety is a pharmacophore for inhibition of rat microsomal ACAT.
View MoreQingdao XinYongAn Chemicals Co., Ltd
Contact:+86-532-81107967
Address:Chengyang dual-port industrial park by the sea,Qingdao
Shandong Green Bio-Pharmaceutical Co.,Ltd
Contact:+86-530-5408622
Address:High-tech Development Zone, Heze City, Shandong, China
Chengdu Cogon Bio-tech Co., Ltd.
Contact:86-28-85171192
Address:NO.52.YongFeng Rd. Chengdu,610041,P.R.China.
Beijing ZhongDaXinHe Chemical Product Co.,Ltd(expird)
Contact:010-52876516
Address:tongzhoubeiyuan
Shaanxi Lighte Optoelectronics Material Co., Ltd.
Contact:+86-29-88320728-622/619/620
Address:No.55 INDUSTRY ROAD 2,XI'AN NATIONAL CIVIL AEROSPACE INDUSTRIAL PARK.XI'AN China 710065.
Doi:10.1007/BF00503478
(1981)Doi:10.1039/c39850000190
(1985)Doi:10.1021/je00042a047
(1985)Doi:10.1016/S0040-4039(00)98119-X
(1985)Doi:10.1021/jacs.5b07438
(2015)Doi:10.1021/jm00149a029
(1985)